Thank you for visiting my Just Giving page in support of Parkinson’s
Disease research at The University of Sheffield.

As someone who is partial to the odd tipple, and given the
option, nearly always opts to try a new beer, I have decided to have a go at
trying 30 new beers that I have never tried before.

And, no, I’m not doing this all in one go! Throughout the
month of June I will be gradually building up my repertoire of new beers,
tasting, rating and scoring as I go along, until I am able to crown the
champion beer of my challenge!

I will provide updates of my ‘league table’ and you will be
able to see which beers are in pole position as we move into the business end
of the month….

This is to help the University of Sheffield in its quest to
raise money for Parkinson’s Disease Research. This is a cause close to my heart
that has affected my family.

For this reason I was due to run the Sheffield Half Marathon
in March, for Parkinson’s and raised money for this: https://www.justgiving.com/fundraising/dlbuos

This is a cause that I am passionate about, and I had also
intended entering the University’s ‘Big Walk’ in aid of the cause as well. Like
many others, it doesn’t quite seem real that these strange times have resulted
in both events not taking place as planned. Therefore, I am delighted that The
Big 30 has given me the opportunity to continue to contribute.

The University of Sheffield needs help to carry on their
important research into Parkinson's. Every day, our researchers are working to
find a cure for this devastating disease.

Two more people are diagnosed every hour, that’s 18,000
people every year. Causing a huge loss of physical movement and uncontrollable
tremors, the disease will affect 145,000 people in the UK alone in 2020. New
treatments are needed to stop Parkinson's in its tracks.

With clinicians and scientists working together at Sheffield,
our unique bench-to-bedside approach is a beacon of medical research best
practice.

Donations will support this important work, helping our
researchers to lead the way in developing new treatments for Parkinson's
Disease.